{"nct_id":"NCT02730312","title":"PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2016-08","start_date_type":"ACTUAL","primary_completion_date":"2021-09","primary_completion_date_type":"ACTUAL","completion_date":"2021-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["XNCR"]}